Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page
- Check3 days agoChange DetectedThe content now omits the 'Schizophrenia' condition label, the 'related topics:' header, and the 'MedlinePlus Genetics' link, reducing visible context about the study condition and related health information.SummaryDifference0.0%

- Check10 days agoChange DetectedNew quick-access navigation items were added (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading formatting was updated; the page now shows an updated Revision tag (Revision: v3.6.0).SummaryDifference0.2%

- Check17 days agoChange DetectedThe Revision line on the page was updated from v3.5.4 to v3.5.5, representing a small update to the page revision.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page's related topics now include Schizophrenia and MedlinePlus Genetics, and the revision tag was updated from v3.5.3 to v3.5.4.SummaryDifference0.1%

- Check46 days agoChange DetectedSchizophrenia, related topics, and MedlinePlus Genetics references were removed from the page, changing how the study’s condition and related educational resources are presented to users. This affects the contextual framing of the trial without altering the underlying data.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating a new release/version of the page. This change reflects a minor update to the page's release notes/history without altering the study details visible to users.SummaryDifference0.0%

Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.